RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy

9Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

RNA-based therapies have been promising method for treating all kinds of diseases, and four siRNA-based drugs and two mRNA-based drugs have been approved and are on the market now. However, none of them is applied for cancer treatment. This is not only because of the complexity of the tumor microenvironment, but also due to the intrinsic obstacles of RNAs. Until now, all kinds of strategies have been developed to improve the performance of RNAs for cancer therapy, especially the nanoparticle-based ones using biogenic materials. They are much more compatible with less toxicity compared to the ones using synthetic polymers, and the most widely studied biogenic materials are oligonucleotides, exosomes, and cell membranes. Particular characteristics make them show different capacities in internalization and endosomal escape as well as specific targeting. In this paper, we systematically summarize the RNA-based nano-delivery systems using biogenic materials for cancer therapy, and we believe this review will provide a valuable reference for researchers involved in the field of biogenic delivery and RNA-based therapies for cancer treatment.

Cite

CITATION STYLE

APA

Li, N., Sun, Y., Fu, Y., & Sun, K. (2021, December 24). RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy. Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2021.734443

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free